ID

13192

Description

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults; ODM derived from: https://clinicaltrials.gov/show/NCT00697242

Link

https://clinicaltrials.gov/show/NCT00697242

Keywords

  1. 1/23/16 1/23/16 -
Uploaded on

January 23, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis B NCT00697242

Eligibility Hepatitis B NCT00697242

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
healthy male or female subjects between 50 and 70 years old.
Description

Age, Gender, Health status

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0424576
written informed consent will have been obtained from the subjects.
Description

written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
good physical condition as established by physical examination and history taking at the time of entry
Description

physical condition

Data type

boolean

Alias
UMLS CUI [1]
C0424576
UMLS CUI [2]
C1142435
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
positive titres for anti hepatitis antibodies
Description

anti hepatitis antibodies

Data type

boolean

Alias
UMLS CUI [1]
C0019161
UMLS CUI [2]
C0019164
any vaccination against hepatitis b in the past.
Description

hepatitis b vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0474232
any previous administration of mpl
Description

administration of mpl

Data type

boolean

Alias
UMLS CUI [1]
C0066776
elevated serum liver enzymes at two subsequent determinations 14 days apart.
Description

serum liver enzymes

Data type

boolean

Alias
UMLS CUI [1]
C1287351
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
Description

Comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
axillary temperature > 37.5°c at the time of injection.
Description

axillary temperature

Data type

boolean

Alias
UMLS CUI [1]
C1531924
UMLS CUI [2]
C0039476
any acute disease at the moment of entry.
Description

acute diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009488
chronic alcohol consumption.
Description

alcoholism

Data type

boolean

Alias
UMLS CUI [1]
C0038586
any treatment with immunosuppressive or immunostimulant therapy.
Description

immunosuppressive therapy or immunostimulant therapy

Data type

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0001551
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
Description

chronic drug treatment

Data type

boolean

Alias
UMLS CUI [1]
C0013216
history of allergic disease likely to be stimulated by any component of the vaccine.
Description

allergic diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0020517
administration of any other vaccine(s) or any immunoglobulin during the study period.
Description

vaccine(s) or any immunoglobulins

Data type

boolean

Alias
UMLS CUI [1]
C0042210
UMLS CUI [2]
C0021027
simultaneous participation in any other clinical trial.
Description

participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Hepatitis B NCT00697242

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age, Gender, Health status
Item
healthy male or female subjects between 50 and 70 years old.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0424576 (UMLS CUI [3])
written informed consent
Item
written informed consent will have been obtained from the subjects.
boolean
C0021430 (UMLS CUI [1])
physical condition
Item
good physical condition as established by physical examination and history taking at the time of entry
boolean
C0424576 (UMLS CUI [1])
C1142435 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
anti hepatitis antibodies
Item
positive titres for anti hepatitis antibodies
boolean
C0019161 (UMLS CUI [1])
C0019164 (UMLS CUI [2])
hepatitis b vaccination
Item
any vaccination against hepatitis b in the past.
boolean
C0474232 (UMLS CUI [1])
administration of mpl
Item
any previous administration of mpl
boolean
C0066776 (UMLS CUI [1])
serum liver enzymes
Item
elevated serum liver enzymes at two subsequent determinations 14 days apart.
boolean
C1287351 (UMLS CUI [1])
Comorbidity
Item
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
boolean
C0009488 (UMLS CUI [1])
axillary temperature
Item
axillary temperature > 37.5°c at the time of injection.
boolean
C1531924 (UMLS CUI [1])
C0039476 (UMLS CUI [2])
acute diseases
Item
any acute disease at the moment of entry.
boolean
C0009488 (UMLS CUI [1])
alcoholism
Item
chronic alcohol consumption.
boolean
C0038586 (UMLS CUI [1])
immunosuppressive therapy or immunostimulant therapy
Item
any treatment with immunosuppressive or immunostimulant therapy.
boolean
C0021079 (UMLS CUI [1])
C0001551 (UMLS CUI [2])
chronic drug treatment
Item
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
boolean
C0013216 (UMLS CUI [1])
allergic diseases
Item
history of allergic disease likely to be stimulated by any component of the vaccine.
boolean
C0009488 (UMLS CUI [1])
C0020517 (UMLS CUI [2])
vaccine(s) or any immunoglobulins
Item
administration of any other vaccine(s) or any immunoglobulin during the study period.
boolean
C0042210 (UMLS CUI [1])
C0021027 (UMLS CUI [2])
participation status
Item
simultaneous participation in any other clinical trial.
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial